Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neurodegeneration in multiple sclerosis is a process separate from inflammation: Yes.
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.
Natalizumab treatment for multiple sclerosis inducing a toxic acute myocardial damage. Is there any relationship?
Body fluid biomarkers for multiple sclerosis-the long road to clinical application.
A history of multiple sclerosis investigations in Canada between 1850 and 1950.
Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis.
Alemtuzumab for relapsing-remitting multiple sclerosis.
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.
The harm of ham hocks: Foreign body impaction in long-standing multiple sclerosis.
Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling.
Designed Glucopeptides Mimetics of Myelin Protein Epitopes As Synthetic Probes for the Detection of Autoantibodies, Biomarkers of Multiple Sclerosis.
S1P1 Receptor Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist.
Expression of vitamin d receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
Bacillus thuringiensis poisoning related acute transverse myelitis.
Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot study.
The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis.
IL-17 induces MIP-1α expression in primary mouse astrocytes via TRPC channel.
MicroRNA regulation of lymphocyte tolerance and autoimmunity.
Prolactin Is Not Required for the Development of Severe Chronic Experimental Autoimmune Encephalomyelitis.
Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US.
Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, placebo-controlled, double-blind trial.
Postural orthostatic tachycardia syndrome associated with multiple sclerosis.
High spatial and angular resolution diffusion-weighted imaging reveals forniceal damage related to memory impairment.
Treatment of Acute Relapses in Multiple Sclerosis.
Pages
« first
‹ previous
…
306
307
308
309
310
311
312
313
314
…
next ›
last »